logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
B

Byoung Chul Cho

yonsei cancer center

106H-index
1.6KPaper Count
7.0WCitation Count
Published Papers 393
Publication Date
logo
Integrative stratification of response to immunotherapy using host and microbial signatures in patients with advanced non-small cell lung cancer
errGenome Medicine
IF11.2
err2026-08-06
err0
errOAAI
errJii Bum Lee; Junwon Yang; Mauricio Chalita; Yeonjae Jung; Haangik Park; Myungja Ro; Hyun Kim; Eunchong Yang; Soeun Choi; Minyoung Kim; Arim Min; Bo-Eun Kwon; Jieun Im; Hyunjeong Kim; Hyunkyung Park; Sun Min Lim; Min Hee Hong; Sein Park; Yeong Ouk Kim; Jongsik Chun; Hyun-Seok Oh; Byoung Chul Cho
errShare
errSave
Author Correction: SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
errNature Medicine
IF50
err2026-06-29
err0
errOAAI
errLauren Averett Byers; Byoung Chul Cho; Alissa J. Cooper; Anne C. Chiang; Ji-Youn Han; Muhammad Furqan; Afshin Dowlati; Daniel Morgensztern; Kyriakos P. Papadopoulos; Noura J. Choudhury; María Vieito; Jair Bar; Joo-Hang Kim; Wallace Akerley; Tae Min Kim; Young-Chul Kim; Luis Paz-Ares; Myung-Ju Ahn; Hiroshi Yokouchi; Darius Meiman; Wijith Munasinghe; Oluwadamilola Ogunyankin; Nadine Jahchan; Song Wang; Cristiano Ferlini; Randy R. Robinson; Frederick J. Kohlhapp; Tammy Palenski; Guillermo Rivell; Pooja Hingorani; Sreenivasa Chandana
errShare
errSave
Durvalumab plus etoposide–platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD
errLung Cancer
IF4.4
err2026-06-18
err0
PREAI
errIsamu Okamoto; Byoung Chul Cho; Sarah B. Goldberg; Jonathan W. Goldman; Adrianus J. de Langen; Zofia Piotrowska; Jonathan W. Riess; Helena A. Yu; MRosario Garcia Campelo; Jeremy Cetnar; Yu Jung Kim; Silvia Novello; Yoshimasa Shiraishi; Helen Ambrose; Paul E. Smith; Kwan Ho Tang; Jonathan M. Lehman; Xiuning Le
errShare
errSave
Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor
errBIOORGANIC & MEDICINAL CHEMISTRY LETTERS
IF2.2
err2026-05-23
err0
PREAI
errCyriac, Rajath; Lee, Eun Ji; Kwon, Yeongju; Yun, Mi Ran; Jung, Myoung Eun; Ahn, Sunjoo; Chae, Chang Hak; Choi, Gildon; Cho, Byoung Chul; Lee, Kwangho
errShare
errSave
Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD
errEuropean Journal of Cancer
IF7.1
err2026-05-18
err0
PREAI
errZofia Piotrowska; Sarah B. Goldberg; Jonathan W. Goldman; Adrianus J. de Langen; Xiuning Le; Isamu Okamoto; Jonathan W. Riess; Helena A. Yu; Kazumi Nishino; Silvia Novello; Santiago Ponce; Helen Ambrose; Paul. E. Smith; Kwan Ho Tang; Jonathan. M. Lehman; Byoung Chul Cho
errShare
errSave
MORPHEUS-Lung: biomarkers and clinical response to atezolizumab + bevacizumab + stereotactic body radiotherapy in patients with metastatic non-small cell lung cancer
errLung Cancer
IF4.4
err2026-05-07
err0
PREAI
errByoung Chul Cho; Sun Min Lim; Sang Hoon Lee; Dong Kwon Kim; Nuria Pardo; Hen Prizant; Yaacov R. Lawrence; Nedal Al-Sakaff; Hans-Joachim Helms; Velimir Gayevskiy; Barzin Y. Nabet; Jan Pintoffl; Francois Ghiringhelli
errShare
errSave
Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies
errCancer
IF5.1
err2026-04-24
err0
errOAAI
errTae Min Kim MD, PhD; Stephen K. Williamson MD; Kyriakos P. Papadopoulos MD; Omid Hamid MD; Grace K. Dy MD; Ray McDermott MD; Ariel Birnbaum MD; John M. Kaczmar MD; Nehal Lakhani MD; Danny Rischin MD; Debashis Sarker MD; Afshin Dowlati MD; Xin-Hua Zhu MD; Jyoti Malhotra MD; Jean-Francois Pouliot PhD; Jayakumar Mani PhD; Laura Brennan DrPH; Fang Fang PhD; Shuquan Chen PhD; Mark Salvati PhD; Israel Lowy MD; Ahmed Khaled MD; Karl D. Lewis MD; Glenn Kroog MD; Matthew G. Fury MD, PhD; Byoung Chul Cho MD
errShare
errSave
Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypes
errTranslational Lung Cancer Research
IF3.5
err2026-03-23
err0
PREAI
errYoon, Dayoung; Lee, Ji Won; Cho, Byoung Chul; Kang, Eun Joo; Kim, Jung Sun; Lim, Taekyu; Yi, Seong Yoon; Kim, Yu Jung; Ahn, Mi Sun; Kim, Young Saing; Park, Ji Hyun; Lim, Seungtaek; Park, Hyung Soon; Cho, Jang Ho; Jang, Byunghyun; Lee, Ji Yoon; Kim, Jiwon; Hong, Jisoo; Koo, Harim; Chung, Seok; Shin, Sang Won; Kim, Yeul Hong; Sa, Jason K.; Choi, Yoon Ji
errShare
errSave
Overall survival for amivantamab plus lazertinib versus osimertinib as first-line treatment in Asian participants with EGFR-mutant advanced NSCLC: A MARIPOSA subset analysis
errLung Cancer
IF4.4
err2026-02-04
err0
PREAI
errHidetoshi Hayashi; Byoung Chul Cho; Yu Jung Kim; Se-Hoon Lee; Pongwut Danchaivijitr; Adlinda Alip; Hailin Xiong; Soon-Hin How; Gee-Chen Chang; James Chih-Hsin Yang; Yuta Yamanaka; Mehmet Ali Nahit Şendur; Kumar Prabhash; Koichi Azuma; Alianu Akawung; Elizabeth Fennema; Xiaodan Tang; Sujay Shah; Seema Sethi; Shun Lu
errShare
errSave
Amivantamab plus chemotherapy versus chemotherapy for first-line treatment of participants with EGFR exon 20 insertion-mutated advanced non-small cell lung cancer: PAPILLON Asia subgroup analysis
errLung Cancer
IF4.4
err2026-02-02
err0
PREAI
errCaicun Zhou; Ke-Jing Tang; Baogang Liu; Sang-We Kim; Satoru Kitazono; Akira Ono; Muthukkumaran Thiagarajan; Jen-Yu Hung; Michael Boyer; Timuçin Çİl; Yu Yao; Rajnish Nagarkar; John Xie; Archan Bhattacharya; Honeylet Wortman-Vayn; Mahadi Baig; Trishala Agrawal; Patricia Lorenzini; Se-Hoon Lee; Byoung Chul Cho
errShare
errSave
Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer
errESMO Open
IF8.3
err2026-01-27
err0
errOAAI
errJ.B. Lee; K.H. Kim; S. Yoon; S.Y. Song; S.S. Lee; S. Jo; H.K. Ahn; H.J. Kim; S.J. Choi; H. Park; M.H. Hong; B.C. Cho; H.I. Yoon; S.M. Lim
errShare
errSave
A Response to the Letter to the Editor: “Comparable or Indeterminate? A Critical Appraisal of Efficacy Claims in the MARIPOSA Exploratory Analysis”
errJournal of Thoracic Oncology
IF20.8
err2025-12-03
err0
PREAI
errSe-Hoon Lee; Shun Lu; John Xie; Sujay Shah; Seema Sethi; Byoung Chul Cho
errShare
errSave
Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29)
errEsophagus
IF3.8
err2025-12-01
err1
PREAI
errHong, Min Hee; Shin, Sung Kwan; Choi, Su-Jin; Ahn, Beung-Chul; Kim, Hye Ryun; Park, Seong Yong; Kim, Dae Joon; Lee, Chang Geol; Cho, Jaeho; Kim, Jong Hoon; Kim, Hyeong Ryul; Kim, Yong-Hee; Lee, Gang-Taik; Park, Sook Ryun; Lee, Sang Kil; Cho, Byoung Chul
errShare
errSave
Modeling the metastatic tumor microenvironment: a co-culture platform of lung cancer and blood vessel organoids for drug evaluation
errScientific Reports
IF3.9
err2025-11-24
err0
errOAAI
errMingyun Lee; Yeo-Joon Yoon; Ji Yeon Lee; Mina Hwang; Sewon Park; Min Hak Lee; Sang-Won Um; Byoung Chul Cho; Jinguen Rheey; Toshiro Sato; Yong Soo Lee
errShare
errSave
Response to the Letter to the Editor: “Lazertinib in EGFR-Mutated NSCLC with CNS Metastases: Reinforcing the Role of Third-Generation TKIs through Pooled Analysis”
errClinical Lung Cancer
IF3.3
err2025-11-19
err0
PREAI
errByoung Chul Cho; YuKyung Kim
errShare
errSave
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study
errESMO Open
IF8.3
err2025-11-18
err0
errOAAI
errJ.-P. Metges; K. Kato; J.-M. Sun; L. Shen; P.C. Enzinger; A. Adenis; T. Doi; T. Kojima; Z. Li; S.-B. Kim; B.C. Cho; W. Mansoor; S.-H. Li; P. Sunpaweravong; M. Alsina; G.L. Buchschacher; H. Hara; A. Tsuji; J. Wu; S. Shah
errShare
errSave
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer
errLung Cancer
IF4.4
err2025-11-07
err0
PREAI
errByoung Chul Cho; Chaiyut Charoentum; Dong-Wan Kim; Cheng-Ta Yang; Rafal Dziadziuszko; Sarayut Lucien Geater; Helen Mann; Banafsheh Afshar-Imani; Pavlo Lyfar; James Chih-Hsin Yang; Sandip Pravin Patel
errShare
errSave
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
errTargeted Oncology
IF4
err2025-11-03
err0
errOAAI
errRachel E. Sanborn; Caicun Zhou; Ke-Jing Tang; Byoung Chul Cho; Susanna Cheng; Sanjay Popat; Akira Ono; Shun Lu; Margarita Majem; Andres Aguilar; Maria Del Rosario Garcia Campelo; Hidetoshi Hayashi; Kang-yun Lee; Se-Hoon Lee; Angelo Delmonte; Jorge Alatorre-Alexander; Gary Richardson; Victor Santos; Christophe Dooms; Joshua K. Sabari; Catherine A. Shu; Nicolas Girard; Aaron S. Mansfield; Keunchil Park; Yichuan Xia; Archan Bhattacharya; Nasuh Buyukkaramikli; Nolen Perualila; Joris Diels; Sandip Acharya; Conor Chandler; Irina Proskorovsky; Lindsay Dearden; Honeylet Wortman-Vayn; Parthiv J. Mahadevia; Roland E. Knoblauch; Trishala Agrawal; Mahadi Baig; Enriqueta Felip
errShare
errSave
First-Line Sacituzumab Govitecan Plus Pembrolizumab in Metastatic NSCLC: PD-L1 TPS <50% and ≥50% Cohorts of the EVOKE-02 Study
errJournal of Thoracic Oncology
IF20.8
err2025-10-30
err0
PREAI
errMartin Reck; Jyoti D. Patel; Jhanelle E. Gray; Noemí Reguart; Manuel Cobo; José Fuentes Pradera; Enriqueta Felip; Federico Cappuzzo; Edward B. Garon; Joel W. Neal; Sabeen Mekan; Farnoush Safavi; Nelumka Fernando; Marianna Zavodovskaya; Juliane M. Jürgensmeier; Michael Chisamore; Byoung Chul Cho
errShare
errSave
A comparison of clinical guidelines; treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America
errFrontiers in Oncology
IF3.3
err2025-10-27
err0
errOAAI
errChi-Lu Chiang; Ross Andrew Soo; Tony Mok; Pei Jye Voon; Lucksamon Thamlikitkul; Ying Cheng; Hidehito Horinouchi; Byong Chul Cho; Krista Lin Xu; Myung-Ju Ahn†
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Pasi A. Jänne
H-index: 163 · Papers: 2.3K
J
James Chih‐Hsin Yang
H-index: 141 · Papers: 1.2K
Y
Yi‐Long Wu
H-index: 135 · Papers: 2.2K
R
Roy S. Herbst
H-index: 134 · Papers: 1.3K
T
Tony Mok
H-index: 131 · Papers: 1.1K
View more